The report for Middle-East and Africa Hypertension Drugs Market of Market Research
Future comprises of extensive primary research along with the detailed analysis of
qualitative as well as quantitative aspects by various industry experts, key opinion leaders
to gain the deeper insight of the market and industry performance. Middle-East and Africa
Hypertension Drugs Market information, by Type (Thiazide diuretics, Beta blockers,
Angiotensin-converting enzyme (ACE) inhibitors, Angiotensin II receptor blockers, Calcium
channel blockers, Renin inhibitors, Alpha blockers, Alpha-beta blockers, Central-acting
agents, Vasodilators, Aldosterone antagonists, and others) - Forecast to 2022
Hypertension or high blood pressure is the condition when blood pressure increases to the
unhealthy level. Hypertension is very harmful and it can lead to stroke, heart failure, heart
attack and kidney diseases. The main purpose of anti-hypertension drug is to lower and
control high blood pressure to protect organs like brain, heart, kidneys. Hypertension affects
four out of ten adults in Middle East and Africa region. Over 1.5 million deaths occurs due to
hypertension in Middle East and Africa. Countries in Middle East and Africa bear a heavy
burden from hypertension diagnosis and treatment. Huge funding in R&D and various
initiatives by government are driving the growth for Hypertension Drugs Market in Middle
East and Africa. Middle-East and Africa Hypertension Drugs Market is growing moderately.
The market is growing at the CAGR of 3.1% and expected to reach to US$ 5.31 billion by
2022.
Middle-East and Africa Hypertension Drugs Market has been segmented on the basis of type
which comprise Thiazide diuretics, Beta blockers, Angiotensin-converting enzyme (ACE)
inhibitors, Angiotensin II receptor blockers, Calcium channel blockers, Renin inhibitors,
Alpha blockers, Alpha-beta blockers, Central-acting agents, Vasodilators, Aldosterone
antagonists, and others.
Key Players for Middle-East and Africa Hypertension Drugs Market:
Some of the key players in this market are: Abbott (US), Johnson & Johnson Services, Inc.
(US), Novartis (Switzerland), GlaxoSmithKline plc.(UK), AstraZeneca (UK), Bayer AG
(Germany), Pfizer Inc.(US), Merck & Co., Inc. (US), Sanofi (France), F. Hoffmann-La Roche
Ltd (Switzerland), Gilead (US)
Get Sample Copy @ https://www.marketresearchfuture.com/sample_request/2636 .
Regional Analysis of Middle-East and Africa Hypertension Drugs Market:
Considering the Middle-East and Africa Hypertension Drugs Market scenario, UAE region is
believed to be the largest market for Middle-East and Africa Hypertension Drugs. Moreover
Saudi Arabia market is also growing and second largest market for Hypertension Drugs. On
the other hand, Egypt market is expected to grow at the steady pace in the Middle-East and
Africa Hypertension Drugs during the forecasted period. Rest of the Middle East and Africa
region is likely to have a limited but steady growth in the market.